QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company is headquartered in Venlo, Limburg and currently employs 5,700 full-time employees. The firm is engaged in providing Sample to Insight solutions that transform biological samples into molecular insights. Its Sample to Insight solutions integrate sample and assay technologies, bioinformatics and automation systems. Its sample technologies are used for isolating and preparing deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and proteins from blood or other liquids, tissue, plants or other materials. Its assay technologies make these biomolecules visible for analysis, such as identifying the genetic information of a pathogen or a gene mutation in a tumor. Its bioinformatics solutions interpret data to provide actionable insights. The firm's automation platforms based on polymerase chain reaction (PCR), next-generation sequencing (NGS) and other technologies tie these together in molecular testing workflows from Sample to Insight.
Follow-Up Questions
Qiagen NV (QGEN)'in P/E oranı nedir?
Qiagen NV 'in P/E oranı 118.3673 'dir
Qiagen NV 'in CEO'su kimdir?
Mr. Thierry Bernard 2020 'den beri şirketle birlikte olan Qiagen NV 'in Chief Executive Officer 'ıdır.
QGEN hissesinin fiyat performansı nasıl?
QGEN 'in mevcut fiyatı $45.94 'dir, son işlem günde 0.01% increased etti.
Qiagen NV için ana iş temaları veya sektörler nelerdir?
Qiagen NV Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
Qiagen NV 'in piyasa değerlemesi nedir?
Qiagen NV 'in mevcut piyasa değerlemesi $9.9B 'dir
Qiagen NV al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 18 analist Qiagen NV için analist derecelendirmeleri gerçekleştirdi, bunlar 5 güçlü al, 8 al, 11 tut, 0 sat ve 5 güçlü sat içermektedir
